Three Main Mutational Pathways in HIV-2 Lead to High-Level Raltegravir and Elvitegravir Resistance: Implications for Emerging HIV-2 Treatment Regimens

Overview of attention for article published in PLOS ONE, September 2012

Altmetric Badge

Mentioned by

policy: 1 policy source
twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Open Access, 18 Sep 2012

by Robert A. Smith, Dana N. Raugi, Charlotte Pan, Matthew Coyne, Alexandra Hernandez, Brad Church, Kara Parker, James I. Mullins…